Navigation Links
Medpace Strengthens Presence in Central Europe

CINCINNATI and PRAGUE, Czech Republic, Aug. 21 /PRNewswire/ -- Medpace, Inc., a leading global full-service contract research organization, today announced it has completed the acquisition of Monax s.r.o., a regional contract research organization (CRO) headquartered in Prague, Czech Republic. This move strengthens the Medpace presence in Central Europe and expands its capacity to provide full service clinical research management within the Czech Republic and Slovakia. Petr Potuznik, MD, the founder of Monax, will continue to lead Medpace clinical operations for the region.

"We are excited to welcome the Monax team to the Medpace family," said August Troendle, MD, Medpace Chief Executive Officer. "The expertise of Dr. Petr Potuznik and his highly trained team fit perfectly within our strategic global expansion plan."

"We have worked closely with Medpace in the past and found that our companies shared a high level of expertise and commitment to quality," said Potuznik. "Becoming part of the Medpace group allows the Monax team to grow and expand our presence and capabilities throughout the region."

About Medpace

Medpace is a global, research-based drug development company led by top therapeutic and regulatory experts who are driven to further the advancement of pharmaceutical agents for use in cardiology, metabolism, and oncology. Medpace has assembled the industry's most experienced and therapeutically focused team to execute at every level of the company's operations, providing complete and seamless drug development services.

Through specialized regulatory expertise and therapeutically focused clinical operations, Medpace creates strategic partnerships with pharmaceutical and biotechnology companies to provide the most efficient and cost-effective path to drug development - from program planning and execution to product approval.

With more than 500 employees and clinical trial experience in nearly 40 countries, Medpace has the global reach and capability to conduct studies and navigate regulatory requirements worldwide within the core therapeutic areas of cardiology, metabolism, and oncology.

The Medpace group of companies also includes

Imagepace - a centralized imaging laboratory with expertise in cIMT

Medpace Reference Laboratory - a centralized lab with therapeutically specialized testing

Medpace Clinical Pharmacology - a Phase I/IIa unit scheduled to open in Q1, 2008.

Contact: Stephanie Lusk 513-579-9911 x1102

SOURCE Medpace, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BIO 2007: Wisconsin makes its presence felt
2. TDS trades markets to gain Duluth presence
3. West Coast VC Establishes Midwest Presence in Madison
4. Sony Bets Heavy on Wisconsin Digital Entertainment Presence
5. Madison start-up Central Signal gets $350K grant
6. Will wireless Internet bypass the central city?
7. Norlight to expand fiber network into central Illinois
8. Centralization mania takes over
9. Meterologix Media Division acquired by Madison-based Weather Central
10. Weather Central launches second satellite
11. Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
Post Your Comments:
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... Inc., a worldwide provider of clinical research services headquartered in ... has set a new quarterly earnings record in Q3 of 2015.  ... Q3 of 2014 to Q3 of 2015.   ... the establishment of an Asia-Pacific office to ... and Mexico , with the establishment ...
(Date:11/24/2015)... 24, 2015 --> ... report released by Transparency Market Research, the global non-invasive ... CAGR of 17.5% during the period between 2014 and ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... testing market to reach a valuation of US$2.38 bn ...
Breaking Biology Technology:
(Date:11/19/2015)...  Based on its in-depth analysis of the biometric ... the 2015 Global Frost & Sullivan Award for Product ... this award to the company that has developed the ... the market it serves. The award recognizes the extent ... customer base demands, the overall impact it has in ...
(Date:11/17/2015)... PARIS , November 17, 2015 ... 17 au 19 novembre  2015.  --> Paris ... 2015.  --> DERMALOG, le leader de l,innovation ... à la fois passeports et empreintes sur la même ... pour les passeports et l,autre pour les empreintes digitales. ...
(Date:11/12/2015)... CAMBRIDGE, Mass. , Nov. 12, 2015 /PRNewswire/ ... Broad Institute of MIT and Harvard for use ... chemical discovery information management tools. The partnership will ... share both biological and chemical research information internally ... tools will be used for managing the Institute,s ...
Breaking Biology News(10 mins):